Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0RY4M
|
||||
Former ID |
DNC000757
|
||||
Drug Name |
Hyoscine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Phase 4 | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C17H21NO4
|
||||
Canonical SMILES |
CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
|
||||
InChI |
1S/C17H21NO4/c1-18-13-7-11(8-14(18)16-15(13)22-16)21-17(20)12(9-19)10-5-3-2-4-6-10/h2-6,11-16,19H,7-9H2,1H3/t11?,12?,13-,14-,15-,16+/m0/s1
|
||||
InChIKey |
STECJAGHUSJQJN-OYVHKFOJSA-N
|
||||
CAS Number |
CAS 1239-45-8
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
ChEBI ID |
ChEBI:4883
|
||||
SuperDrug ATC ID |
A04AD01
|
||||
SuperDrug CAS ID |
cas=000051343
|
||||
Target and Pathway | |||||
Target(s) | Muscarinic acetylcholine receptor M5 | Target Info | Antagonist | [2] | |
KEGG Pathway | Calcium signaling pathway | ||||
Neuroactive ligand-receptor interaction | |||||
Cholinergic synapse | |||||
Regulation of actin cytoskeleton | |||||
PANTHER Pathway | Alzheimer disease-amyloid secretase pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Reactome | Muscarinic acetylcholine receptors | ||||
G alpha (q) signalling events | |||||
WikiPathways | Monoamine GPCRs | ||||
Calcium Regulation in the Cardiac Cell | |||||
Regulation of Actin Cytoskeleton | |||||
GPCRs, Class A Rhodopsin-like | |||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
References | |||||
REF 1 | ClinicalTrials.gov (NCT02098889) Safety Study of Hyoscine N Butyl Bromide in Active Management of Labor. U.S. National Institutes of Health. | ||||
REF 2 | Comparison of the effects of a selective muscarinic receptor antagonist and hyoscine (scopolamine) on motion sickness, skin conductance and heart rate. Br J Clin Pharmacol. 1997 Jun;43(6):633-7. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.